share_log
Benzinga ·  Aug 6 08:03
Tonix Pharmaceuticals Publishes Research On High-Throughput Screening Assay For Neutralizing Antibodies Against SARS-CoV-2 Variants; Study Showcases Internal R&D Capabilities, Including NIH-Selected COVID-19 Vaccine And DoD/DTRA Awarded Anti-Viral Program
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment